RESUMEN
Background: In women at low risk of PPH, recent studies have suggested that active pharmacological management does not reduce blood loss when compared with physiological management and routine use of oxytocic drugs benefits only seven women per hundred. The aim of study is to study the effect of prolonged duration of third stage labour on risk of hemorrhage Methods: This was a hospital based prospective randomized controlled trial study. Institutional Ethics Committee permission was obtained. Informed consent was taken from each and every woman who participated in the study. A total of 500 women in third stage of labour were divided into two groups of 250 each. The outcome was measured in terms of blood loss and hemoglobin percentage. Results: It is observed that the duration of III stage labour was more among control group where the cord was clamped compared to study group where the cord was drained. Similarly it was also observed that the blood loss was also more among control group compared to study group, both in multigravida and primigravida. It is seen that there was a fall of 1.1% of hemoglobin in primigravida in study group compared to 1% among control group in primigravida. Similar result was seen for multigravida women. Conclusion: Routine drug administration is unnecessary for all low risk women.